CSIMarket
 


Vera Therapeutics Inc   (VERA)
Other Ticker:  
 

Vera Therapeutics Inc 's Total Debt to Equity

VERA's quarterly Total Debt to Equity and Total Debt, Equity growth


Due to net new borrowings of 0.32%, Total Debt to Equity fell to 0.2, above the Vera Therapeutics Inc 's average Total Debt to Equity.

Within Major Pharmaceutical Preparations industry in the third quarter 2023, 53 other companies have achieved lower Total Debt to Equity than Vera Therapeutics Inc in the III Quarter 2023. While Total Debt to Equity total ranking has deteriorated compared to the second quarter 2023 from 438 to 738 .

Explain Debt to Equity Ratio?
What is the structure of VERA´s Total Debt?
How valuable is the VERA´s Equity?


VERA Total Debt to Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change 17.02 % 15.65 % 17.32 % 10.51 % 23.68 %
Y / Y Total Debt Change 404.27 % 404.08 % 404.07 % 403.96 % -
Total Debt to Equity MRQ 0.2 0.18 0.16 0.32 0.05
VERA's Total Ranking # 738 # 438 # 641 # 1052 # 312
Seq. Equity Change -11.97 % -10.9 % 105.06 % -27.25 % -12.99 %
Seq. Total Debt Change 0.32 % 0.31 % 0.31 % 399.6 % 0.28 %



Total Debt to Equity third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 54
Healthcare Sector # 133
Overall Market # 738


Total Debt to Equity Statistics
High Average Low
0.32 0.13 0.04
(Dec 31 2022)  




Financial Statements
Vera Therapeutics Inc 's Equity $ 124 Millions Visit VERA's Balance sheet
Vera Therapeutics Inc 's Total Debt $ 25 Millions Visit VERA's Balance sheet
Source of VERA's Sales Visit VERA's Sales by Geography


Cumulative Vera Therapeutics Inc 's Total Debt to Equity

VERA's Total Debt to Equity for the trailling 12 Months

VERA Total Debt to Equity

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth 17.02 % 15.65 % 17.32 % 10.51 % 23.68 %
Y / Y Total Debt TTM Growth 404.27 % 404.08 % 404.07 % 403.96 % -
Total Debt to Equity TTM 0.2 0.17 0.13 0.09 0.05
Total Ranking TTM # 677 # 51 # 30 # 37 # 20
Seq. Equity TTM Growth -11.97 % -10.9 % 105.06 % -27.25 % -12.99 %
Seq. Total Debt TTM Growth 0.32 % 0.31 % 0.31 % 399.6 % 0.28 %


On the trailing twelve months basis Due to the net new borrowings of 0.32% during the trailing twelve months finishing in the III Quarter 2023, cumulativeTotal Debt to Equity improved to 0.2, a new company high.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 63, during the past 12 months, other companies have achieved lower Total Debt to Equity than Vera Therapeutics Inc . While Total Debt to Equity total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 51 to 677.

Explain Debt to Equity Ratio?
What is the structure of VERA´s Total Debt?
How valuable is the VERA´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 64
Healthcare Sector # 144
Within the Market # 677


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.2 0.09 0.03
(Sep 30 2023)   (Mar 31 2022)




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Total Debt to EquitySep 30 2023 MRQ Total DebtSep 30 2023 MRQ Equity
Lucy Scientific Discovery Inc   0.52 $ 1.398  Millions$ 2.702  Millions
China Pharma Holdings Inc   0.51 $ 3.133  Millions$ 6.111  Millions
Oramed Pharmaceuticals Inc   0.51 $ 75.363  Millions$ 148.230  Millions
Aytu Biopharma Inc   0.50 $ 16.119  Millions$ 32.167  Millions
Mersana Therapeutics Inc   0.48 $ 25.155  Millions$ 52.195  Millions
Verastem inc   0.48 $ 40.057  Millions$ 83.180  Millions
Celularity Inc   0.46 $ 14.006  Millions$ 30.247  Millions
Johnson and Johnson  0.42 $ 29,921.000  Millions$ 71,228.000  Millions
Rockwell Medical inc   0.42 $ 8.962  Millions$ 21.518  Millions
Harmony Biosciences Holdings inc   0.41 $ 197.131  Millions$ 481.332  Millions
Apellis Pharmaceuticals Inc   0.40 $ 92.957  Millions$ 232.271  Millions
Uniqure N v   0.38 $ 101.431  Millions$ 268.784  Millions
Dynavax Technologies Corporation  0.37 $ 222.415  Millions$ 604.916  Millions
Cumberland Pharmaceuticals Inc  0.36 $ 12.923  Millions$ 35.656  Millions
Werewolf Therapeutics Inc   0.35 $ 39.231  Millions$ 112.443  Millions
Eton Pharmaceuticals Inc   0.34 $ 5.737  Millions$ 16.892  Millions
Roivant Sciences Ltd   0.33 $ 438.443  Millions$ 1,325.633  Millions
Earth Science Tech Inc   0.31 $ 0.599  Millions$ 1.934  Millions
Centessa Pharmaceuticals Plc  0.29 $ 74.000  Millions$ 259.390  Millions
Abvc Biopharma Inc   0.28 $ 2.507  Millions$ 9.062  Millions
Hcw Biologics Inc   0.27 $ 6.333  Millions$ 23.867  Millions
Kineta Inc   0.26 $ 0.765  Millions$ 2.889  Millions
Organogenesis Holdings Inc   0.24 $ 67.600  Millions$ 276.865  Millions
Legend Biotech Corporation  0.22 $ 281.384  Millions$ 1,251.371  Millions
Biomarin Pharmaceutical Inc  0.22 $ 1,085.984  Millions$ 4,896.897  Millions
Alkermes Plc   0.21 $ 291.366  Millions$ 1,355.583  Millions
Cue Biopharma Inc   0.21 $ 9.123  Millions$ 42.666  Millions
Innovation Pharmaceuticals Inc   0.20 $ 0.238  Millions$ 1.162  Millions
Vera Therapeutics Inc   0.20 $ 25.042  Millions$ 123.707  Millions
Assertio Holdings inc   0.20 $ 38.866  Millions$ 192.873  Millions

Date modified: 2023-11-12T11:06:50+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com